Adjunctive antibiotic/anticoagulant lock therapy in the treatment of bacteremia associated with the use of a subcutaneously implanted hemodialysis access device

ASAIO Journal

Volumn 46, Issue 6, 2000, Pages 767-770

  Boorgu, R ^d   Dubrow, A J ^a   Levin, N W ^a   My, H ^c   Canaud, B J ^b   Lentino, J R ^d   Wentworth, D W ^d   Hatch, D A ^d   Megerman, J ^e   Prosl, F R ^e   Gandhi, V C ^d   Ing, Todd S ^d,f  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b LAPEYRONIE HOSPITAL   (France)

^c CENTRE HOSPITALIER SAINT JOSEPH SAINT LUC   (France)

^d Veterans Affairs Medical Center in Hines   (United States)

^e Biolink Corporation   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA; BLOOD; CATHETERS; DIALYSIS; DISEASES; DRUG PRODUCTS; IMPLANTS (SURGICAL);

ADJUNCTIVE ANTIBIOTIC ANTICOAGULANT LOCK THERAPY; BACTEREMIA; INFECTIONS; SUBCUTANEOUSLY IMPLANTED HEMODIALYSIS ACCESS DEVICE; SUPERIOR VENA CAVA;

DRUG THERAPY;

AMIKACIN; AMOXICILLIN; ANTIBIOTIC AGENT; BENZATHINE PENICILLIN; CEFAZOLIN; CIPROFLOXACIN; GENTAMICIN; OFLOXACIN; PIPERACILLIN; VANCOMYCIN;

ANTIBIOTIC THERAPY; ANTICOAGULATION; ARTICLE; BACTEREMIA; CATHETER INFECTION; COMBINATION CHEMOTHERAPY; DEVICE; DRUG EFFICACY; HEMODIALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INDWELLING CATHETER; VASCULAR ACCESS;

EID: 0034326832     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002480-200011000-00021     Document Type: Article

References (30)

1. Permanent vascular access: A nephrologist's view
2. Prospective evaluation of a dacron cuffed hemodialysis catheter for prolonged use
3. Excerpts from the USRDS 1997 Annual report, IV: The USRDS dialysis morbidity and mortality study. Wave 2
4. Hemodialysis vascular access morbidity
5. Initial results of a new access device for hemodialysis: Technical note
6. Dialock: A new vascular access device for extracorporeal renal replacement therapy. Preliminary clinical results
7. New access device for hemodialysis
8. Development of a new approach to vascular access
9. Antibiotic lock in the treatment of infections associated with the use of a subcutaneously implanted hemodialysis access device
10. Haemodialysis catheter-related infection: Time for action
11. The hemodialysis catheter conundrum: Hate living with them, but can't live without them
12. Elimination of intraluminal colonization by antibiotic lock in silicone vascular catheters
13. Bacterial biofilms: A common cause of persistent infections
14. Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis
15. Antibiotic-lock technique: A new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients
16. Treatment of hickman catheter sepsis using antibiotic lock technique
17. Intraluminal antibiotic treatment of central venous catheter infections in patients receiving parenteral nutrition at home
18. Minocycline and ethylenediaminetetraacetate for the prevention of recurrent vascular catheter infections
19. Management of intravascular catheter-related infections
20. Antibiotic lock technique
21. Gentamicin/sodium-citrate mixture as antibiotic-lock technique for salvage and prevention of catheterrelated infections: A four year trial
22. Insufficient penetration of systemic vancomycin into the PermCath lumen
23. Successful treatment of haemodialysis catheter-related sepsis without catheter removal
24. Clinical results of the German DIALOCK® access study: A new subcutaneous port system and a novel antimicrobial lock solution
25. Incompatibilities in intravenous solution
26. Persistent staphylococcal bacteremia in an intravenous drug abuser
27. Heparin sodium
28. Intravenous infusions of heparin and penicillins
29. Stability of antibiotics used for antibioticlock treatment of infections of implantable venous devices (ports)
30. Vancomycin and teicoplanin